SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-049165
Filing Date
2021-08-02
Accepted
2021-08-02 21:36:51
Documents
1
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4180
  Complete submission text file 0001209191-21-049165.txt   5639
Mailing Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016
Business Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016 (646) 600-6438
IN8BIO, INC. (Issuer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IN8BIO,INC. 79 MADISON AVENUE NEW YORK NY 10016
Business Address
Whitfill Travis (Reporting) CIK: 0001830178 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39692 | Film No.: 211137661